Latest Breaking News On - Molecular imaging program - Page 2 : comparemela.com

Molecular imaging improves staging and treatment of pancreatic ductal adenocarcinomas

Molecular imaging improves staging and treatment of pancreatic ductal adenocarcinomas
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.

National institutes of healthUnited statesBaden wübergVirgin islandsStefana koerberFrederikl gieselPatrick naumannPeterl choykeRebecca maxeyUwe haberkornKlaus herfarthMatthias langAnnika wefersFrederik gieselClemens kratochwilFabian staudinger

Novel radiopharmaceutical tracks master switch protein responsible for cancer growth

Novel radiopharmaceutical tracks master switch protein responsible for cancer growth
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.

Stanford universityUnited statesCorinne beinatAndrei iagaruLewis nayaTom haywoodLawrence rechtGuido davidzonTarik massoudSanjiv gambhirChirag patelJessa castilloSociety of nuclear medicineNuclear medicineMolecular imagingMolecular imaging program

Karmanos Cancer Institute presents 2021 Heroes of Cancer Awards

Karmanos Cancer Institute presents 2021 Heroes of Cancer Awards These awards honor individuals and organizations who raise awareness of all types of cancers and advocate for a cure News provided by Share this article Share this article DETROIT, April 15, 2021 /PRNewswire/ The Barbara Ann Karmanos Cancer Institute is pleased to announce the winners of its 2021 Heroes of Cancer Awards. This year s event celebrates Karmanos 26th year of honoring individuals and organizations that have distinguished themselves and inspired others as they advocate for and raise awareness of all types of cancers. Award winners will be honored at a virtual event on Wednesday, April 21, 7-8 p.m. The public is invited to attend.

Wayne state universityUnited statesBay cityHarper woodsWayne state university school of medicineBloomfield hillsLaurel beth strompelJeffreyd formanRobert morrisGerold beplerMicheline wentworthAnn delisiHayley thompsonJeffrey formanAl rokerDavid cook

Immuno-PET can give physicians early insight into tumor response to targeted therapy

E-Mail IMAGE: Three receptor tyrosine kinases (RTKs) EGFR (orange), HER2 (pink), and MET (green) are imaged before and after the use of a MET-selective tyrosine kinase inhibitor (Trametinib), and trametinib, a mitogen activated protein. view more Credit: Image created by Patricia Pereira, PhD, Research Associate at Memorial Sloan Kettering Cancer Center Reston, VA Immuno-positron emission tomography (PET) imaging can provide early insight into a tumor s response to targeted therapy, allowing physicians to select the most effective treatment for patients who have cancer. The new research was published in the March issue of The Journal of Nuclear Medicine. The research showed that immuno-PET successfully visualizes changes in different cancer receptors (receptor tyrosine kinases, or RTKs) within tumors during targeted therapies. This gives physicians a tool that can be used to evaluate the effectiveness of a treatment soon after its administration.

New yorkUnited statesNational institutes of healthMemorial sloan kettering cancer centerJalen norfleetRebecca maxeyAlice goodwinPatricia pereiraJason lewisFreddye escorciaPatriciamr pereiraFreddy escorciaJasons lewisMolecular imaging programJournal of nuclear medicineDepartment of radiology

Firma Clinical Commences Scientific Advisory Board

Firma Clinical Commences Scientific Advisory Board Board Includes Experts from Harvard, Stanford, UConn and a former FDA Director News provided by Share this article Share this article CHICAGO, March 10, 2021 /PRNewswire/ Firma Clinical, a niche service provider to clinical research organizations, recently commenced a Scientific Advisory Board for its clinical services, including biometrics/data. The board includes scientific experts from Harvard University, Stanford University and the University of Connecticut and the FDA s former Director of the Division of Biostatistics. The board members provide Firma with strategic advice and education and are resources for the latest statistical methodology and regulatory requirements.

United statesSoochow universityT ai peiYing luPalo altoStanford universityDana farber cancer instituteHarvard universityHarvard school of public healthPatty pologrutoEugenia henryEarl webb henryMing hui chenGreg campbellMichael woodsDejun tang